Cornerstone Planning Group’s Bio-Techne TECH Stock Holding History

Cornerstone Planning Group’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.88K	Buy	87 +12	+16%	+$720	﹤0.01%	1091
2025 Q4	$4.92K	Sell	75 -27	-26%	-$1.64K	﹤0.01%	992
2025 Q3	$788	Buy	102 +22	+28%	+$1.18K	﹤0.01%	1369
2025 Q2	$4.37K	Buy	80 +62	+344%	+$3.12K	﹤0.01%	756
2025 Q1	$903	Sell	18 -12	-40%	-$813	﹤0.01%	1162
2024 Q4	$2.29K	Buy	30 +26	+650%	+$1.91K	﹤0.01%	761
2024 Q3	$283	Sell	4 -10	-71%	-$751	﹤0.01%	1209
2024 Q2	$1.09K	Buy	+14	New	+$1.03K	﹤0.01%	917
2022 Q4	$1.62K	Buy	+20	New	+$1.59K	﹤0.01%	1246

Other funds holding TECH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cornerstone Planning Group's TECH Position: Q1 2026 in Review

Cornerstone Planning Group increased its Bio-Techne (TECH) stake by 16% in Q1 2026, buying an estimated $720 and bringing the position to 87 shares worth $4.88K. The position accounts for ﹤0.01% of the portfolio, ranked #1091.

Cornerstone Planning Group first reported a position in TECH in Q4 2022 and has held it in 9 quarters since. The position peaked at $4.92K in Q4 2025. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

Cornerstone Planning Group held 87 shares of Bio-Techne worth $4.88K as of Q1 2026.
Cornerstone Planning Group bought 12 Bio-Techne shares in Q1 2026, an estimated $720.
Bio-Techne made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q1 2026, its #1091 holding.
Cornerstone Planning Group first reported a position in Bio-Techne in Q4 2022 and has held it in 9 quarters since.
Cornerstone Planning Group's Bio-Techne position peaked at $4.92K in Q4 2025.
582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Cornerstone Planning Group's 13F filing for Q1 2026, filed 6 May 2026.